AKERO THERAPEUTICS

HQ - South San Francisco, California

Summary

Akero Therapeutics, a U.S. clinical-stage biotech focused on metabolic liver disease.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 3.51 B

Avg. Deal Size£ 3.51 B

Market Context